Cargando…

Targeting cistrome and dysregulated transcriptome of post-MPN sAML

Detalles Bibliográficos
Autores principales:	Verstovsek, Srdan, Fiskus, Warren, Manshouri, Taghi, Bhalla, Kapil N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706789/ https://www.ncbi.nlm.nih.gov/pubmed/29212143 http://dx.doi.org/10.18632/oncotarget.21752

Ejemplares similares

Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells
por: Fiskus, Warren, et al.
Publicado: (2022)

Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells
por: Fiskus, Warren, et al.
Publicado: (2021)

Novel BET protein Proteolysis Targeting Chimera (BET-PROTAC) exerts superior lethal activity than Bromodomain Inhibitor (BETi) against post-myeloproliferative Neoplasm (MPN) Secondary (s) AML Cells
por: Saenz, Dyana T., et al.
Publicado: (2017)

BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells
por: Saenz, Dyana T., et al.
Publicado: (2016)

Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy
por: Vaxevanis, Christoforos K., et al.
Publicado: (2022)

Factors associated with the number and size of renal angiomyolipomas in sporadic angiomyolipoma (sAML): a study of adult patients with sAML managed in a Dutch tertiary referral center
por: Ruud Bosch, J. L. H., et al.
Publicado: (2018)

Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
por: Javorniczky, Nora Rebeka, et al.
Publicado: (2023)

Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1
por: Feld, Christine, et al.
Publicado: (2018)

Altered T-cell subset repertoire affects treatment outcome of patients with myelofibrosis
por: Veletic, Ivo, et al.
Publicado: (2020)

EVI1 dysregulation: impact on biology and therapy of myeloid malignancies
por: Birdwell, Christine, et al.
Publicado: (2021)

GLI1 activates pro-fibrotic pathways in myelofibrosis fibrocytes
por: Manshouri, Taghi, et al.
Publicado: (2022)

HEXIM1 induction is mechanistically involved in mediating anti-AML activity of BET protein bromodomain antagonist
por: Devaraj, Santhana G. T., et al.
Publicado: (2015)

Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
por: Fiskus, Warren, et al.
Publicado: (2014)

Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
por: Fiskus, Warren, et al.
Publicado: (2023)

Immune Dysregulation and Infectious Complications in MPN Patients Treated With JAK Inhibitors
por: Cattaneo, Daniele, et al.
Publicado: (2021)

Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells
por: Fiskus, Warren, et al.
Publicado: (2014)

Ruxolitinib for essential thrombocythemia?
por: Bose, Prithviraj, et al.
Publicado: (2017)

Primary myelofibrosis marrow-derived CD14(+)/CD34(-) monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes
por: Manshouri, Taghi, et al.
Publicado: (2019)

Ovarian ERβ cistrome and transcriptome reveal chromatin interaction with LRH-1
por: Birgersson, Madeleine, et al.
Publicado: (2023)

Enabling Secure XMPP Communications in Federated IoT Clouds Through XEP 0027 and SAML/SASL SSO
por: Celesti, Antonio, et al.
Publicado: (2017)

Cistrome: an integrative platform for transcriptional regulation studies
por: Liu, Tao, et al.
Publicado: (2011)

ChIPing the cistrome of PXR in mouse liver
por: Cui, Julia Yue, et al.
Publicado: (2010)

The PAX8 cistrome in epithelial ovarian cancer
por: Adler, Emily K., et al.
Publicado: (2017)

To bind or not to bind: Cistromic reprogramming in prostate cancer
por: Shen, Michelle, et al.
Publicado: (2022)

Targeting glutamine uptake in AML
por: Jacque, Nathalie, et al.
Publicado: (2014)

Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and MDS/MPN diseases. Differences between MDS and MDS/MPN
por: Mestrum, Stefan G. C., et al.
Publicado: (2020)

ELF5 modulates the estrogen receptor cistrome in breast cancer
por: Piggin, Catherine L., et al.
Publicado: (2020)

Methylome, transcriptome, and PPARγ cistrome analyses reveal two epigenetic transitions in fat cells
por: Takada, Hitomi, et al.
Publicado: (2014)

The native cistrome and sequence motif families of the maize ear
por: Savadel, Savannah D., et al.
Publicado: (2021)

Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry
por: Kaifie, A., et al.
Publicado: (2016)

Solving Identity Management in Modern Applications: Demystifying OAuth 2.0, OpenID Connect, and SAML 2.0
por: Wilson, Yvonne
Publicado: (2019)

Securing Web services with WS-Security: demystifying WS-Security, WS-Policy, SAML, XML Signature, and XML Encryption
por: Rosenberg, Jonathan B, et al.
Publicado: (2004)

Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer
por: Venkannagari, Sreedhar, et al.
Publicado: (2012)

The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN
por: Spivak, Jerry L., et al.
Publicado: (2021)

HLX in AML: novel prognostic and therapeutic target
por: Pandolfi, Ashley, et al.
Publicado: (2012)

Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1
por: Mill, Christopher P., et al.
Publicado: (2023)

Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1
por: Fiskus, Warren, et al.
Publicado: (2022)

The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
por: Pomerantz, Mark M., et al.
Publicado: (2015)

Deciphering essential cistromes using genome-wide CRISPR screens
por: Fei, Teng, et al.
Publicado: (2019)

Sea-ATI unravels novel vocabularies of plant active cistrome
por: Wen, Chenjin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2u070s83e5293o60n3bko7gp3d